Cargando…

Tool for Guidance: Evidence-Based Recommendations for Managing Febrile Neutropenia

Detalles Bibliográficos
Autor principal:	Ullmann, Andrew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110844/ https://www.ncbi.nlm.nih.gov/pubmed/21716588 http://dx.doi.org/10.3904/kjim.2011.26.2.135

Ejemplares similares

Developments in the management of febrile neutropenia
por: Pascoe, J
Publicado: (2011)

Timely Assessment and Management of Febrile Neutropenia
por: Viale, Pamela Hallquist
Publicado: (2019)

Management of chemotherapy-associated febrile neutropenia
por: Cameron, D
Publicado: (2009)

Clinical practice in secondary prophylaxis and management of febrile neutropenia in Poland: results of the febrile neutropenia awareness project
por: Wojtukiewicz, Marek, et al.
Publicado: (2014)

Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations
por: Aapro, Matti, et al.
Publicado: (2017)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)

Outpatient management of febrile neutropenia in children with cancer
por: Ziino, Ottavio, et al.
Publicado: (2011)

Impact of effective prevention and management of febrile neutropenia
por: Krell, D, et al.
Publicado: (2009)

Update on the management of febrile neutropenia in hematologic patients
por: Escrihuela-Vidal, Francesc, et al.
Publicado: (2019)

Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients
por: Monuszko, Karen A., et al.
Publicado: (2021)

Guidance Statement for the Management of Febrile Neutropenia in Pediatric Patients Receiving Cancer-Directed Therapy in Central America and the Caribbean
por: Melgar, Mario, et al.
Publicado: (2020)

The Dutch Working Party on Antibiotic Policy (SWAB) Recommendations for the Diagnosis and Management of Febrile Neutropenia in Patients with Cancer
por: de la Court, J. R., et al.
Publicado: (2022)

Coronaviruses in children with febrile neutropenia
por: Alvares, Paula A., et al.
Publicado: (2013)

Febrile neutropenia with bacterial paronychia
por: Hosono, Yuki, et al.
Publicado: (2018)

Febrile Neutropenia in Transplant Recipients
por: Nesher, Lior, et al.
Publicado: (2018)

Febrile Neutropenia in Children with Cancer
por: Paulus, Stéphane, et al.
Publicado: (2008)

Febrile neutropenia in paediatric oncology
por: Davis, Kimberly, et al.
Publicado: (2020)

Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy
por: Hashiguchi, Yasunori, et al.
Publicado: (2015)

Use of biomarkers in the management of febrile neutropenia episodes in children with cancer()
por: de Oliveira, Benigna Maria
Publicado: (2016)

Clozapine-Induced Febrile Neutropenia and Cellulitis
por: YAYLACI, Selcuk, et al.
Publicado: (2016)

Acute Myelogenous Leukemia and Febrile Neutropenia
por: Herbers, Alexandra, et al.
Publicado: (2009)

How I Treat Febrile Neutropenia
por: Nucci, Marcio
Publicado: (2021)

Febrile neutropenia studies in Brazil - treatment and cost management based on analyses of cases
por: Bellesso, Marcelo
Publicado: (2013)

Clinical practice in febrile neutropenia risk assessment and granulocyte colony-stimulating factor primary prophylaxis of febrile neutropenia in Poland
por: Wojtukiewicz, Marek, et al.
Publicado: (2014)

Best Practices in the Management of Infectious Complications for Patients With Cancer: Management of Febrile Neutropenia
por: Molina, Kyle C.
Publicado: (2023)

Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance
por: Akyol, Mehmet Umut, et al.
Publicado: (2019)

Recommendations for the management of MPS VI: systematic evidence- and consensus-based guidance
por: Akyol, Mehmet Umut, et al.
Publicado: (2019)

Management of febrile neutropenia in the United Kingdom: time for a national trial?
por: Innes, H, et al.
Publicado: (2005)

Prevention of febrile neutropenia: use of prophylactic antibiotics
por: Cullen, M, et al.
Publicado: (2009)

Secondary Infections in Cancer Patients with Febrile Neutropenia
por: Azap, Alpay, et al.
Publicado: (2012)

COST OF FEBRILE NEUTROPENIA TREATMENT IN BOSNIA AND HERZEGOVINA
por: Catic, Tarik, et al.
Publicado: (2016)

Serum Endocan Levels in Children with Febrile Neutropenia
por: Kiral, Eylem, et al.
Publicado: (2016)

Testicular Abscess an Unusual Cause for Febrile Neutropenia
por: Grenader, Tal
Publicado: (2008)

Prevalence of Fungemia in Pediatric Patients with Febrile Neutropenia
por: Meidani, Mohsen, et al.
Publicado: (2018)

Investigation of seasonal frequency and pathogens in febrile neutropenia
por: Özdemir, Seray Karagöz, et al.
Publicado: (2019)

Diagnostic Radiology in Hematological Patients with Febrile Neutropenia
por: Heussel, Claus Peter
Publicado: (2014)

Risk factors for bacteremia in children with febrile neutropenia
por: KARA, Soner Sertan, et al.
Publicado: (2019)

203. Opportunities for Antimicrobial Stewardship in Febrile Neutropenia
por: Shoff, Christopher, et al.
Publicado: (2020)

The application of nanopore targeted sequencing in the diagnosis and antimicrobial treatment guidance of bloodstream infection of febrile neutropenia patients with hematologic disease
por: Hong, Mei, et al.
Publicado: (2023)

COVID-19 Prevention Guidance and the Incidence of Febrile Neutropenia in Patients with Breast Cancer Receiving TAC Chemotherapy with Prophylactic Pegfilgrastim
por: Gwak, Hongki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lsk90g0alru9mbs1mu9hk71m6k